Lenovo Group's Huang Shan: Delivering Truly "Usable" Computing Power to Healthcare Sector

Deep News
2025/12/20

On December 20, the "Intelligent Computing Synergy in Healthcare: Ecosystem Linking the Future" themed seminar was held in Chengdu. Lenovo Group, together with ecosystem partners like Intel, clients, and media representatives, visited Xunshang Healthcare to discuss innovative applications of intelligent computing technology in AI+ healthcare.

Lenovo Group has been actively expanding its presence in AI+ healthcare, having developed a scenario-based smart healthcare solution centered on "AI large models + RPA + integrated platform" for Xunshang Healthcare. By establishing an enterprise-level integrated platform and Clinical Data Repository (CDR), Lenovo helps hospitals aggregate, manage, and standardize data scattered across multiple systems such as HIS, orders, and finance. This creates a unified "360-degree holographic patient view," enabling intelligent enhancements across patient treatment processes and internal operational management, achieving a leap from "data accumulation" to "data governance."

Huang Shan, Strategic Management Director of Lenovo China's Infrastructure Business Group, emphasized during the event: "Robust AI factory infrastructure and continuously evolving computing engines form the cornerstone for supporting smart healthcare applications and ensuring their stable, efficient operation. As a leading AI infrastructure provider, Lenovo is leveraging its technological capabilities to deliver truly 'usable' computing power to the healthcare sector, enabling broader access to high-quality medical resources."

Huang further explained that based on this solid data foundation, Lenovo has deployed its AI middleware and full lifecycle model management capabilities. This allows the "Xunshang AI Hospital" project to achieve continuous and agile model iteration. Lenovo's toolchain and platform support distillation training and targeted optimization of privately deployed large models (such as DeepSeek R1) based on specific knowledge bases, ensuring model capabilities keep pace with the latest developments in clinical practice and medical knowledge. This represents a shift from "one-time delivery" to "continuous evolution."

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10